0001193125-26-306072.txt : 20260716 0001193125-26-306072.hdr.sgml : 20260716 20260716160104 ACCESSION NUMBER: 0001193125-26-306072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260714 FILED AS OF DATE: 20260716 DATE AS OF CHANGE: 20260716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mohindru Mani CENTRAL INDEX KEY: 0001664708 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 261180332 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiff Oncology, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Trovagene, Inc. DATE OF NAME CHANGE: 20130304 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 4 1 ownership.xml 4 X0609 4 2026-07-14 0001213037 Cardiff Oncology, Inc. CRDF 0001664708 Mohindru Mani false 11055 FLINTKOTE AVENUE C/O CARDIFF ONCOLOGY, INC. SAN DIEGO CA 92121 true true false false Chief Executive Officer false Common Stock 2026-07-14 4 P false 34364 1.455 A 59067 D Common Stock Purchase Warrant 1.33 2026-07-14 4 P false 34364 0 A Common Stock 34364 34364 D Exercisable beginning on the later of (i) six months after issuance or (ii) the Authorized Share Increase Date (the "Initial Exercise Date"). "Authorized Share Increase Date" means the date on which an amendment to the Issuer's certificate of incorporation increasing the number of authorized shares of its common stock to an amount sufficient for the exercise in full of the Common Warrants is filed with and accepted by the State of Delaware, subject to approval of such amendment by its stockholders. The term of exercise is equal to five and one-half years after the Initial Exercise Date. /s/ Mani Mohindru 2026-07-16